SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-125055
Filing Date
2023-12-11
Accepted
2023-12-11 17:25:50
Documents
1
Period of Report
2023-12-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2332647-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2332647-2_4seq1.xml 4 8145
  Complete submission text file 0001104659-23-125055.txt   9708
Mailing Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169
Business Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169 212-847-9841
Y-mAbs Therapeutics, Inc. (Issuer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address RUNGSTED STRANDVEJ 113 RUNGSTED KYST G7 2960
Business Address RUNGSTED STRANDVEJ 113 RUNGSTED KYST G7 2960 45-45-17-77-77
WG Biotech ApS (Reporting) CIK: 0001753193 (see all company filings)

State of Incorp.: G7 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38650 | Film No.: 231479369